Simple tests may head off unneeded MRIs for hip pain

Patients who have marked lateral hip pain within 30 seconds of performing a single-leg stand on the affected side are highly likely to have gluteal tendinopathy (GT), a painful but largely self-treatable overuse condition, according to a small study published online in the British Journal of Sports Medicine.

The study also showed that patients with the same or similar pain who are not tender to the physician’s touch are unlikely to have GT that would be detected on MRI.

This simple equation is good information for orthopedic specialists to have at hand, given the high cost of unnecessary MRI.

Alison Grimaldi, PhD, of the University of Queensland in Australia and colleagues further note that patients with GT are often misdiagnosed, resulting in inappropriate surgery on top of the imaging.

The research team looked at the cases of 65 participants with lateral hip pain.

They recorded the results following physician palpation of the femur and several pain-provocation tests, then had a radiologist blinded to the in-office findings interpret MRI scans.

“Pain reported within 30 seconds of standing on the affected limb conclusively moves a (nominal) 50 percent pretest probability of GT presence on MRI to a post-test probability of 98 percent (specificity 100 percent),” the authors report.

Meanwhile, “no pain on palpation (80 percent sensitivity) would rule out” GT’s presence, Grimaldi and co-authors write.

The in-office testing is impressive but not foolproof, as 20 participants (31 percent) had GT on MRI that the docs missed on the pain-tolerance tests.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.